仅用于工业应用或科学研究,不可用于人类或动物的临床诊断或治疗,非药用. Regdanvimab (CT-P59) is a human monoclonal antibody that targets the receptor-binding domain of SARS-CoV-2 spike protein, blocking interaction with ACE2 for viral entry. Regdanvimab can be used for the research of COVID-19